Arie C Nieuwenhuijzen Kruseman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arie C Nieuwenhuijzen Kruseman has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Evelien Pijpers
Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands
3 shared publications - Bianca Dumitrescu
Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania
2 shared publications - Anna Caroline Heijckmann
Department of Internal Medicine, Division of Endocrinology, Hospital Bernhoven, Veghel, The Netherlands
1 shared publication B van Bussel
Department of Internal Medicine, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
1 shared publication- Bruce H. R. Wolffenbuttel
University of Groningen, University Medical Center Groningen
1 shared publication - Caroline E. Wyers
Department of Internal Medicine, VieCuri Medical Center , 5912 BL Venlo
1 shared publication
Latest Publications
- 31 January 2009
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 20 (1) , 80-84
Prevalence and clinical determinants of low bone mineral density in anorexia nervosa
- 31 January 2009
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 20 (1) , 80-84
Prevalence and clinical determinants of low bone mineral density in anorexia nervosa
- Open Access
- 5 August 2008
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 9 (1) , 109
Evaluation of patients with a recent clinical fracture and osteoporosis, a multidisciplinary approach
The aetiology of osteoporotic fractures is multifactorial, but little is known about the way to evaluate patients with a recent clinical fracture for the presence of secondary osteoporosis. The purpose of this study was to determine the prevalence of contributors to secondary osteoporosis in patients presenting with a clinical vertebral or non-vertebral fracture. Identifying and correcting these contributors will enhance treatment effect aimed at reducing the risk of subsequent fractures. In a multidisciplinary approach, including evaluation of bone and fall-related risk factors, 100 consecutive women (n = 73) and men (n = 27) older than 50 years presenting with a clinical vertebral or non-vertebral fracture and having osteoporosis (T-score ≤-2.5) were further evaluated clinically and by laboratory testing for the presence of contributors to secondary osteoporosis. In 27 patients, 34 contributors were previously known, in 50 patients 52 new contributors were diagnosed (mainly vitamin D deficiency in 42) and 14 needed further exploration because of laboratory abnormalities (mainly abnormal thyroid stimulating hormone in 9). The 57 patients with contributors were older (71 vs. 64 yrs, p < 0.01), had more vertebral deformities (67% vs. 44%, p < 0.05) and a higher calculated absolute 10-year risk for major (16.5 vs. 9.9%, p < 0.01) and for hip fracture (6.9 vs. 2.4%, p < 0.01) than patients without contributors. The presence of contributors was similar between women and men and between patients with fractures associated with a low or high-energy trauma. We conclude that more than one in two patients presenting with a clinical vertebral or non-vertebral fracture and BMD-osteoporosis have secondary contributors to osteoporosis, most of which were correctable. Identifying and correcting these associated disorders will enhance treatment effect aimed at reducing the risk of subsequent fractures in patients older than 50 years.
- 5 August 2008
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 9 (1) , 109
Open AccessEvaluation of patients with a recent clinical fracture and osteoporosis, a multidisciplinary approach
The aetiology of osteoporotic fractures is multifactorial, but little is known about the way to evaluate patients with a recent clinical fracture for the presence of secondary osteoporosis. The purpose of this study was to determine the prevalence of contributors to secondary osteoporosis in patients presenting with a clinical vertebral or non-vertebral fracture. Identifying and correcting these contributors will enhance treatment effect aimed at reducing the risk of subsequent fractures. In a multidisciplinary approach, including evaluation of bone and fall-related risk factors, 100 consecutive women (n = 73) and men (n = 27) older than 50 years presenting with a clinical vertebral or non-vertebral fracture and having osteoporosis (T-score ≤-2.5) were further evaluated clinically and by laboratory testing for the presence of contributors to secondary osteoporosis. In 27 patients, 34 contributors were previously known, in 50 patients 52 new contributors were diagnosed (mainly vitamin D deficiency in 42) and 14 needed further exploration because of laboratory abnormalities (mainly abnormal thyroid stimulating hormone in 9). The 57 patients with contributors were older (71 vs. 64 yrs, p < 0.01), had more vertebral deformities (67% vs. 44%, p < 0.05) and a higher calculated absolute 10-year risk for major (16.5 vs. 9.9%, p < 0.01) and for hip fracture (6.9 vs. 2.4%, p < 0.01) than patients without contributors. The presence of contributors was similar between women and men and between patients with fractures associated with a low or high-energy trauma. We conclude that more than one in two patients presenting with a clinical vertebral or non-vertebral fracture and BMD-osteoporosis have secondary contributors to osteoporosis, most of which were correctable. Identifying and correcting these associated disorders will enhance treatment effect aimed at reducing the risk of subsequent fractures in patients older than 50 years.
- Open Access
- 20 May 2008
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 9 (1) , 72
Quantitative ultrasound does not identify patients with an inflammatory disease at risk of vertebral deformities
Previous studies from our group have shown that a high prevalence of vertebral deformities suggestive of fracture can be found in patients with an inflammatory disease, despite a near normal bone mineral density (BMD). As quantitative ultrasound (QUS) of the heel can be used for refined assessment of bone strength, we evaluated whether QUS can be used to identify subjects with an inflammatory disease with an increased chance of having a vertebral fracture. 246 patients (mean age: 44 ± 12.4 years) with an inflammatory disease (sarcoidosis or inflammatory bowel disease (IBD)) were studied. QUS of the heel and BMD of the hip (by dual X-ray absorptiometry (DXA)) were measured. Furthermore lateral single energy densitometry of the spine for assessment of vertebral deformities was done. Logistic regression analysis was performed to assess the strength of association between the prevalence of a vertebral deformity and BMD and QUS parameters, adjusted for gender and age. Vertebral deformities (ratio of <0.80) were found in 72 vertebrae of 54 subjects (22%). In contrast to the QUS parameters BUA (broadband ultrasound attenuation) and SOS (speed of sound), T-score of QUS and T-scores of the femoral neck and trochanter (DXA) were lower in the group of patients with vertebral deformities. Logistic regression analysis showed that the vertebral deformity risk increases by about 60 to 90% per 1 SD reduction of BMD (T-score) determined with DXA but not with QUS. Our findings imply that QUS measurements of the calcaneus in patients with an inflammatory condition, such as sarcoidosis and IBD, are likely of limited value to identify patients with a vertebral fracture.
- 20 May 2008
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 9 (1) , 72
Open AccessQuantitative ultrasound does not identify patients with an inflammatory disease at risk of vertebral deformities
Previous studies from our group have shown that a high prevalence of vertebral deformities suggestive of fracture can be found in patients with an inflammatory disease, despite a near normal bone mineral density (BMD). As quantitative ultrasound (QUS) of the heel can be used for refined assessment of bone strength, we evaluated whether QUS can be used to identify subjects with an inflammatory disease with an increased chance of having a vertebral fracture. 246 patients (mean age: 44 ± 12.4 years) with an inflammatory disease (sarcoidosis or inflammatory bowel disease (IBD)) were studied. QUS of the heel and BMD of the hip (by dual X-ray absorptiometry (DXA)) were measured. Furthermore lateral single energy densitometry of the spine for assessment of vertebral deformities was done. Logistic regression analysis was performed to assess the strength of association between the prevalence of a vertebral deformity and BMD and QUS parameters, adjusted for gender and age. Vertebral deformities (ratio of <0.80) were found in 72 vertebrae of 54 subjects (22%). In contrast to the QUS parameters BUA (broadband ultrasound attenuation) and SOS (speed of sound), T-score of QUS and T-scores of the femoral neck and trochanter (DXA) were lower in the group of patients with vertebral deformities. Logistic regression analysis showed that the vertebral deformity risk increases by about 60 to 90% per 1 SD reduction of BMD (T-score) determined with DXA but not with QUS. Our findings imply that QUS measurements of the calcaneus in patients with an inflammatory condition, such as sarcoidosis and IBD, are likely of limited value to identify patients with a vertebral fracture.
- 1 December 2007
- Published by Oxford University Press (OUP)
- Vol. 83 (986) , 763-767
Polymorbidity in diabetes in older people: consequences for care and vocational training
Objective: To investigate the prevalence of complicating and concurrent morbidities in older diabetic patients and to evaluate to what extent their occurrence affects the burden of disease and use of medical healthcare. Study design: Cross-sectional analysis of retrospectively obtained data on comorbidities and use of medical healthcare. Healthcare registration systems were used to retrieve data on 300 patients with diabetes aged ⩾60 years who, according to the severity of their disease and intensity of care required, were treated in a regional general practitioner (GP), diabetes nurse specialist (DNS) or medical specialist (MS) practice. Results: Complicating and concurrent morbidities were often found irrespective of the type of practice involved. After adjustments for differences in sex, age and glycosylated haemoglobin (HbA1c), the extent of complicating comorbidities showed sequential increases in patients managed by GP, DNS and MS (mean number of 3.6, 4.7 and 6.7, respectively; ptrend<0.001). However, the mean number of concurrent comorbidities was similar across all three settings (2.1, 1.8 and 2.0, respectively). Both complicating and concurrent comorbidities were similarly associated with the extent of drug use (β = 0.49 (95% CI 0.40 to 0.58) and β = 0.57 (95% CI 0.52 to 0.72), respectively) and the number of consultations with specialists other than the main care giver (β = 1.19 (95% CI 1.15 to 1.24) and β = 1.21 (95% CI 1.14 to 1.28), respectively). However, the mean number of different specialists involved in a patient's care per additional concurrent comorbidity was twice as high as per any additional complicating comorbidity (β = 0.60 (95% CI 0.48 to 0.71) vs β = 0.31 (95% CI 0.24 to 0.39)). Conclusions: The use of healthcare facilities by older patients with diabetes is substantial, irrespective of the complexity of the disease and the kind of practice involved. The common manifestation of complicating and concurrent comorbidities and their varying complexity in individual patients requires a patient-oriented rather than a disease-oriented approach and vocational training programmes for care givers that are tailored to the complexity of multiple chronic diseases.
- 1 December 2007
- Published by Oxford University Press (OUP)
- Vol. 83 (986) , 763-767
Polymorbidity in diabetes in older people: consequences for care and vocational training
Objective: To investigate the prevalence of complicating and concurrent morbidities in older diabetic patients and to evaluate to what extent their occurrence affects the burden of disease and use of medical healthcare. Study design: Cross-sectional analysis of retrospectively obtained data on comorbidities and use of medical healthcare. Healthcare registration systems were used to retrieve data on 300 patients with diabetes aged ⩾60 years who, according to the severity of their disease and intensity of care required, were treated in a regional general practitioner (GP), diabetes nurse specialist (DNS) or medical specialist (MS) practice. Results: Complicating and concurrent morbidities were often found irrespective of the type of practice involved. After adjustments for differences in sex, age and glycosylated haemoglobin (HbA1c), the extent of complicating comorbidities showed sequential increases in patients managed by GP, DNS and MS (mean number of 3.6, 4.7 and 6.7, respectively; ptrend<0.001). However, the mean number of concurrent comorbidities was similar across all three settings (2.1, 1.8 and 2.0, respectively). Both complicating and concurrent comorbidities were similarly associated with the extent of drug use (β = 0.49 (95% CI 0.40 to 0.58) and β = 0.57 (95% CI 0.52 to 0.72), respectively) and the number of consultations with specialists other than the main care giver (β = 1.19 (95% CI 1.15 to 1.24) and β = 1.21 (95% CI 1.14 to 1.28), respectively). However, the mean number of different specialists involved in a patient's care per additional concurrent comorbidity was twice as high as per any additional complicating comorbidity (β = 0.60 (95% CI 0.48 to 0.71) vs β = 0.31 (95% CI 0.24 to 0.39)). Conclusions: The use of healthcare facilities by older patients with diabetes is substantial, irrespective of the complexity of the disease and the kind of practice involved. The common manifestation of complicating and concurrent comorbidities and their varying complexity in individual patients requires a patient-oriented rather than a disease-oriented approach and vocational training programmes for care givers that are tailored to the complexity of multiple chronic diseases.
- 1 November 2007
- Vol. 65 (10) , 363-5
Ageing and polymorbidity: is there a mismatch between the training of internists and the need?
- 1 November 2007
- Vol. 65 (10) , 363-5
Ageing and polymorbidity: is there a mismatch between the training of internists and the need?
- 2 September 2006
- Vol. 150 (35) , 1925-8
[Late-onset hypogonadism in men: uncertain disease entity and reservations regarding treatment with testosterone].
Late-onset hypogonadism (LOH) is defined as insufficient testosterone levels in combination with associated psychological, somatovegetative and sexual symptoms in elderly men. Because the symptomatology of LOH is not specific, it is unclear whether LOH can be considered a clinically relevant entity. At this time, treatment of LOH with testosterone has been shown to have favourable effects on body composition only. The risks of treatment with testosterone appear to be minimal when absolute contraindications (prostate cancer) are observed, although long-term studies on the safety of testosterone therapy are lacking. Restraint in the diagnosis and treatment of LOH is therefore warranted.
- 2 September 2006
- Vol. 150 (35) , 1925-8
[Late-onset hypogonadism in men: uncertain disease entity and reservations regarding treatment with testosterone].
Late-onset hypogonadism (LOH) is defined as insufficient testosterone levels in combination with associated psychological, somatovegetative and sexual symptoms in elderly men. Because the symptomatology of LOH is not specific, it is unclear whether LOH can be considered a clinically relevant entity. At this time, treatment of LOH with testosterone has been shown to have favourable effects on body composition only. The risks of treatment with testosterone appear to be minimal when absolute contraindications (prostate cancer) are observed, although long-term studies on the safety of testosterone therapy are lacking. Restraint in the diagnosis and treatment of LOH is therefore warranted.
- 7 May 2005
- Vol. 149 (19) , 1033-7
[Hormonal and metabolic causes of muscular weakness and the increased risk of fractures in elderly people].
The increased risk of fractures in elderly people is due not only to a decrease in bone mass and bone quality but also to an increased risk of falling. The increased risk of falling is partly a consequence of muscular weakness caused by a decrease in both muscular mass and strength (sarcopenia), in which the hormonal changes that are typical of aging play a pivotal role, as well as of malnutrition, in particular a deficiency of protein, amino acids, calcium and vitamin D. Measures that limit the risk of falling and fractures due to muscular weakness consist mainly of adequate nutrition, extra calcium and vitamin D, reduction of the factors that increase the risk of falling, weight-bearing exercise to strengthen the muscles and the use of hip protectors. Hormonal suppletion has not yet been shown to have a favourable effect, whereas the disadvantages appear to be substantial.
- 7 May 2005
- Vol. 149 (19) , 1033-7
[Hormonal and metabolic causes of muscular weakness and the increased risk of fractures in elderly people].
The increased risk of fractures in elderly people is due not only to a decrease in bone mass and bone quality but also to an increased risk of falling. The increased risk of falling is partly a consequence of muscular weakness caused by a decrease in both muscular mass and strength (sarcopenia), in which the hormonal changes that are typical of aging play a pivotal role, as well as of malnutrition, in particular a deficiency of protein, amino acids, calcium and vitamin D. Measures that limit the risk of falling and fractures due to muscular weakness consist mainly of adequate nutrition, extra calcium and vitamin D, reduction of the factors that increase the risk of falling, weight-bearing exercise to strengthen the muscles and the use of hip protectors. Hormonal suppletion has not yet been shown to have a favourable effect, whereas the disadvantages appear to be substantial.
- 28 February 2005
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 16 (1) , 21-23
What can we learn from undergraduate medical education?
- 28 February 2005
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 16 (1) , 21-23
What can we learn from undergraduate medical education?